Royalty Pharma plc (RPRX)

NMS – Real vaqt narxi. Valyuta: USD

51.70

+0.05 (0.10%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Kompaniya haqida

Royalty Pharma plc Qo'shma Shtatlardagi biofarmatsevtika sanoatida biofarmatsevtika royalti sotib oluvchi va innovatsiyalarni moliyalashtiruvchi sifatida faoliyat yuritadi. Uning portfeli taxminan 35 ta sotuvga chiqarilgan terapiya va rivojlanish bosqichidagi 20 ta mahsulot nomzodlaridan olingan royalti mablag'laridan iborat bo'lib, ular kam uchraydigan kasalliklar, onkologiya, nevrologiya, yuqumli kasalliklar, gematologiya va diabet kabi turli terapevtik sohalarni qamrab oladi. Kompaniya autoimmun kasalliklar uchun tadqiq qilinayotgan dori vositasi JNJ-4804ni ishlab chiqishni rag'batlantirish uchun tadqiqot va ishlanmalar moliyalash hamkorligini yo'lga qo'ygan. Kompaniya 1996 yilda tashkil etilgan va Nyu-York, Nyu-York shahrida joylashgan.

Asosiy rahbarlar

Ism	Lavozim
Dr. James Folmar Reddoch Ph.D.	Executive VP of Investments & Chief Scientific Officer
Dr. Marshall Jonathan Urist M.D., Ph.D.	Executive Vice President of Research & Investments
Mr. Arthur Richard McGivern J.D.	Executive VP & Chief Legal Officer
Mr. Ashwin Pai M.D.	Executive Vice President of Investments & Partnering
Mr. Christopher Hite	Chairman of Partnering & Investments
Mr. Eric Cornelius Schneider